Free Newsletter
Findings could aid vax distribution in developing nations
Collaboration between drugmakers and other movers of cold chain products could help resolve difficulties in the distribution of vaccines and other healthcare products in infrastructure-poor developing nations. One example: Expanding established cold chains to the embassies located within a country.
That's one conclusion of a study conducted by supply chain consultancy Bisham on behalf of the World Health Organization and the nonprofit Program for Appropriate Technology in Health (PATH). Bisham compared health cold-chain logistics models with those of the food industry.
The consultancy finds that local third-party logistics providers (3PLs) need training and capital support from global 3PLs and drugmakers. Government health ministries also must step up in addressing the challenges, but they need "considerable advice, practical help and resources," says Derek Bell, managing director at Bisham, in a trade article.
PATH and WHO expect to begin implementing the recommendations in a phased program that begins this fall.
- here's the article
Related Articles:
Vaccine process shuns the cold
Vaccine platform to aid in pandemic preparedness
Africa rallies against counterfeits
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: